Anna Björkenheim

Artiklar i tidskrifter

• Björkenheim, A. , Kalm, T. , Lidén, M. & Vidlund, M. (2024). Right ventricular lead perforation with iatrogenic injury to an intercostal artery causing haemothorax after pacemaker implant.  BMJ Case Reports, 17 (2). [BibTeX]
• Sztaniszlav, A. , Björkenheim, A. , Magnuson, A. , Bryngelsson, I. , Edvardsson, N. & Poçi, D. (2024). The impact of education level on all-cause mortality in patients with atrial fibrillation.  Scientific Reports, 14 (1). [BibTeX]
• Gottlieb, L. A. , Evans, A. L. , Fuchs, B. , Fröbert, O. & Björkenheim, A. (2023). Translational implications of bradyarrhythmia in hibernating brown bears.  Physiological Reports, 11 (1). [BibTeX]
• Skröder, S. , Wickbom, A. , Björkenheim, A. , Ahlsson, A. , Poçi, D. & Fengsrud, E. (2023). Validation of a handheld single-lead ECG algorithm for atrial fibrillation detection after coronary revascularization.  Pacing and Clinical Electrophysiology, 46 (7), 782-787. [BibTeX]
• Jackson, A. , Fröbert, O. , Boye Larsen, D. , Arendt-Nielsen, L. & Björkenheim, A. (2021). Patients with symptomatic permanent atrial fibrillation show quantitative signs of pain sensitisation.  Open heart, 8 (1). [BibTeX]
• Björkenheim, A. , Szabó, B. & Sztaniszláv, Á. J. (2020). Hereditary transthyretin amyloidosis caused by the rare Phe33Leu mutation.  BMJ Case Reports, 13 (1). [BibTeX]
• Björkenheim, A. , Cha, S. & Dioubanova, I. (2019). Haemolytic anaemia after mitral valve repair due to recurrent mild to moderate mitral regurgitation.  BMJ Case Reports, 12 (8). [BibTeX]
• Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. & Poçi, D. (2018). Patient-Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease-Specific and a Generic Instrument.  Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 7 (5). [BibTeX]
• Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Svedberg, L. , Edvardsson, N. & Poçi, D. (2017). Assessment of Atrial Fibrillation–Specific Symptoms Before and 2 Years After Atrial Fibrillation Ablation: Do Patients and Physicians Differ in Their Perception of Symptom Relief?.  JACC: Clinical Electrophysiology, 3 (10), 1168-1176. [BibTeX]
• Björkenheim, A. , Brandes, A. , Chemnitz, A. , Magnuson, A. , Edvardsson, N. & Poçi, D. (2016). Rhythm Control and its Relation to Symptoms During the First Two Years After Radiofrequency Ablation for Atrial Fibrillation.  Pacing and Clinical Electrophysiology, 39 (9), 914-925. [BibTeX]
• Björkenheim, A. , Brandes, A. , Andersson, T. , Magnuson, A. , Edvardsson, N. , Wandt, B. , Pedersen, H. S. & Poci, D. (2014). Predictors of hospitalization for heart failure and of all-cause mortality after atrioventricular nodal ablation and right ventricular pacing for atrial fibrillation.  Europace, 16 (12), 1772-1778. [BibTeX]

Artiklar, forskningsöversikter

• Björkenheim, A. , Fengsrud, E. & Blomström-Lundqvist, C. (2022). Catheter ablation of symptomatic atrial fibrillation: Sex, ethnicity, and socioeconomic disparities.  Heart rhythm O2, 3 (6 Part B), 766-770. [BibTeX]

Doktorsavhandlingar, sammanläggningar

• Björkenheim, A. (2018). Catheter ablation for atrial fibrillation: effects on rhythm, symptoms and health-related quality of life. (Doctoral dissertation). (Sammanläggning) Örebro: Örebro University. [BibTeX]

Konferensbidrag

• Sztaniszlav, A. , Björkenheim, A. , Magnusson, A. , Edvardson, N. & Poçi, D. (2024). Education level and the incidence of heart failure, acute myocardial infarction, and stroke in patients with atrial fibrillation : a Swedish nationwide cohort study. Konferensbidrag vid ESC Congress 2024, London (Onsite & Online), UK, 30 August-2 September, 2024. [BibTeX]
• Parker, W. A. E. , Sundh, J. , Oldgren, J. , Konstantinidis, K. ,. V. , Lindback, J. , Janson, C. , Andell, P. , Björkenheim, A. & et al. (2023). Prevalence of microspirometry-defined chronic obstructive pulmonary disease in two European cohorts of patients with significant smoking history hospitalised for acute myocardial infarction. I:  Thorax. Konferensbidrag vid Annual Winter Meeting of the British-Thoracic-Society (BTS), London, England, November 22-24, 2023. (ss. A66-A66). BMJ Publishing Group Ltd. [BibTeX]
• Sztaniszlav, A. , Björkenheim, A. , Magnusson, A. , Bryngelson, I. , Edvardson, N. & Poçi, D. (2023). The role of education level in the mortality of hospitalized patients with atrial fibrillation. Konferensbidrag vid EHRA 2023, Barcelona (& Online), Spain, 16-18 April, 2023. Oxford University Press. [BibTeX]
• Jackson, A. , Fröbert, O. , Larsen, D. B. , Arendt-Nielsen, L. & Björkenheim, A. (2021). Patients with symptomatic permanent atrial fibrillation show quantitative signs of pain sensitisation. I:  European Heart Journal. Konferensbidrag vid SC Congress 2021 – The Digital Experience, August 27–30, 2021. (ss. 416-416). Oxford University Press. [BibTeX]
• Björkenheim, A. (2019). Hemolytic anemia and renal failure after mitral valve repair for mitral regurgitation. Konferensbidrag vid ESC Congress, 2019, Paris, France, 31 August-04 September, 2019. [BibTeX]
• Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. & Poci, D. (2018). Patient-reported outcomes in relation to continuously monitored rhythm before and during two years after atrial fibrillation ablation using a disease-specific and a generic instrument. Konferensbidrag vid European Society of Cardiology Congress 2018, Munich, Germany, August 25-29, 2018. [BibTeX]
• Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. G. & Poci, D. (2018). Patient-reported Outcomes In Relation To Continuously Monitored Rhythm Before And During Two Years After Atrial Fibrillation Ablation Using A Disease-specific And A Generic Instrument. Konferensbidrag vid HRS 39th Annual Scientific Sessions, Boston, USA, May 9-12, 2018. [BibTeX]
• Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. & Poçi, D. (2018). Patient-reported outcomes in relation to continuously monitored rhythm before and during two years after atrial fibrillation ablation using a disease-specific and a generic instrument. I:  European Heart Journal. Konferensbidrag vid European-Society-of-Cardiology Congress, Munich, Germany, August 25-29, 2018. (ss. 1415-1415). Oxford University Press. [BibTeX]
• Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Svedberg, L. , Edvardsson, N. & Poçi, D. (2017). Does zero atrial fibrillation burden after atrial fibrillation ablation mean that patients are free of symptoms?. I:  Europace, Supplements. Konferensbidrag vid EHRA EUROPACE - CARDIOSTIM 2017, Vienna, Austria, June 18-21, 2018. (ss. iii264-iii264). Oxford University Press. [BibTeX]
• Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Svedberg, L. , Edvardsson, N. & Poci, D. (2017). Is AF burden <0.5% a clinically meaningful criterion of success after AF ablation?. Konferensbidrag vid 13th Annual Congress of ECAS 2017, Rome, April 2-4, 2017. [BibTeX]